External resources New England Journal of Medicine: Tirzepatide versus semaglutide in type 2 diabetes (SURPASS-2 trial) PMC: Switching between GLP-1 receptor agonists, rationale and practical guidance Endocrine Practice: Switching to tirzepatide from GLP-1 receptor agonists, clinical expectations PMC: The risk of vestibular disorders with semaglutide and tirzepatide In case I do not see you, good afternoon, good evening, and good night
Great place to get healthy." Lesley C
It is easily mixed (usually with some water and fruit juice) and digested
Belperio, Carl Atkinson The complement system has emerged as a critical regulator of intestinal homeostasis, inflammation, and cancer
It is a daily lifestyle choice, and I continue to do well with the help of Dexcom CGM and GLP-1. *Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings
See the conservative titration section below